H&R WASAG sells explosives activities to Maxam/Pravisani
Focus on chemical-pharmaceutical specialty products intensified
The specialty chemicals group based in Salzbergen looks forward to a substantial improvement in its balance sheet ratios as a result of the sale. The equity ratio in particular will undergo a sustained uplift, and the level of net debt will undergo a major reduction.
The explosives and plastics divisions with their earnings and cashflows have in the past formed key pillars of the Group's risk strategy by balancing the impact of the crude oil price on the refinery business, and thereby stabilizing the Group's overall earnings base.
According to the company, the activities of the Chemical-Pharmaceutical Raw Materials Division, which are characterized by a high degree of dependence on the development of the crude oil price, have in the meantime reached a volume that effectively provides a hedge against the effects of a volatile oil market within the division. This allows peripheral activities to be sold, leading to a reduction in the complexity of the specialty chemicals group, and a more defined corporate profile.
Most read news
Organizations
Other news from the department business & finance
Get the chemical industry in your inbox
By submitting this form you agree that LUMITOS AG will send you the newsletter(s) selected above by email. Your data will not be passed on to third parties. Your data will be stored and processed in accordance with our data protection regulations. LUMITOS may contact you by email for the purpose of advertising or market and opinion surveys. You can revoke your consent at any time without giving reasons to LUMITOS AG, Ernst-Augustin-Str. 2, 12489 Berlin, Germany or by e-mail at revoke@lumitos.com with effect for the future. In addition, each email contains a link to unsubscribe from the corresponding newsletter.